paclitaxel has been researched along with Anemia, Hemolytic, Autoimmune in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jain, S; Kaplan, H; Leger, RM; Nester, TA | 1 |
| Inoue, T; Maeda, Y; Maniwa, K; Minakuchi, M; Miyajima, S; Okamoto, M; Sakuramoto, M; Taguchi, Y; Takeda, T; Tanaka, E; Tanizawa, K | 1 |
2 other study(ies) available for paclitaxel and Anemia, Hemolytic, Autoimmune
| Article | Year |
|---|---|
Drug-induced immune hemolytic anemia associated with anti-carboplatin and the first example of anti-paclitaxel.
Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Carboplatin; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel | 2015 |
[A case of pulmonary adenocarcinoma accompanied by minimal change nephrotic syndrome, antiphospholipid syndrome and warm-type autoimmune hemolytic anemia].
Topics: Adenocarcinoma; Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Antiphospholipid Syndrome; Brain Neoplasms; Carboplatin; Cranial Irradiation; Drug Administration Schedule; Humans; Lung Neoplasms; Male; Middle Aged; Nephrosis, Lipoid; Paclitaxel; Prednisolone | 2006 |